Printer Friendly

Bio-Plexus Technology Featured On Dateline NBC.

VERNON, Conn.--(BW HealthWire)--April 7, 1999--Monday evening's Dateline NBC included a moving and informative segment on the topic of accidental needlesticks entitled "On Pins and Needles." The segment told the story of Ellen Dayton, a San Francisco health care worker who was tragically and unnecessarily infected with HIV and hepatitis C through an accidental needlestick from a non-safety needle device. The infection was unnecessary because of the existence of proven safer needle designs.

The story documented the three primary categories of safety needle designs. These include outer sheaths that cover the needle after use; spring retraction which snaps the needle back into a chamber after activation; and internal blunting, which blunts the needle during use -- and before removal from the patient. The story went on to note that safety devices were shown in a Centers for Disease Control study to reduce accidental needlesticks by as much as 76%.

While no devices were mentioned by name in the story, the internal blunt technology featured was the Bio-Plexus Punctur-Guard blood collection needle. Most significantly, the 76% reduction in needlesticks cited in the CDC study reflect Punctur-Guard's performance -- the best results of all devices studied.

The very strong 76% needlestick reduction rate noted in the CDC study with Punctur-Guard's internal blunting method compares very favorably to outer sheath technologies included in the study. Becton Dickinson's Safety-Lok winged infusion set, which uses an outer sheath technology, reduced needlesticks by only 23%. "We believe the disparity in needlestick reduction rates reflects the advantage of our patented internal blunting technology. Punctur-Guard allows the needle to be made safe before removal from the patient, rather than after removal, as with outer sheath technologies," said Tom Sutton, executive vice president at Bio-Plexus.

"There is a major difference in safety effectiveness among the new safety technologies. Investing in safety needles with proven Punctur-Guard internal blunting technology helps ensure that health care facilities get their money's worth, and that health care workers are protected," Sutton added.

The Dateline story further pointed out that only 10% of the five million needles used daily are safety devices. But these figures are changing. Tennessee has now joined California in passing safety needle legislation, bills continue to be introduced in other states, and Federal OSHA is also considering more stringent regulations to protect health care workers from accidental needlesticks.

Bio-Plexus, Inc. (NASDAQ:BPLX), is a designer, developer, manufacturer, and marketer of safety medical products and needles under the PUNCTUR-GUARD(R) and DROP-IT(R) brand names. The company holds U.S. and international patents on safety medical devices designed to reduce the incidence of accidental needlesticks among healthcare workers. Accidental needlesticks number more than one million per year in the United States and can result in the transmission of deadly diseases including HIV and hepatitis.

NOTE: THIS PRESS RELEASE CONTAINS FORWARD-LOOKING STATEMENTS, WHICH ARE SUBJECT TO CHANGE. THE ACTUAL RESULTS MAY DIFFER MATERIALLY FROM THOSE DESCRIBED IN ANY FORWARD-LOOKING STATEMENT.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 
Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Apr 7, 1999
Words:486
Previous Article:GTMI Subsidiary, Bentley House Furniture Company, Projects New Contract Will Generate More Than US$36 Million in Monthly Revenues and US$16 Million...
Next Article:The MEDSTAT Group Successfully Submits JCAHO ORYX Databases for Over 250 Hospitals.
Topics:


Related Articles
Low-cost, high-gain newsmagazines make headlines.
Dateline Midwifery Coverage.
ADVISORY/ Robert Tools, First Recipient of AbioCor Implantable Replacement Heart, To Be Featured on Dateline NBC, Friday, November 2, 2001.
'60 MINUTES' UNDER ATTACK BY RIVAL SHOWS.
PAULEY AMERICA'S SWEETHEART\Former girl in the news has become role model for female TV reporters.
'DATELINE' FACES OFF AGAINST '60 MINUTES'.
NBC LOGS EASY NIELSEN WIN WITH 12 OF TOP 20 SHOWS.
Blind Dateline: in two major stories, NBC news hides the fact that the main subjects were openly gay. Why cover up the truth?
THE BUZZ.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters